• SM-164 Workflow for Apoptosis Research

  2026-08-07

  SM-164 is a bivalent Smac mimetic for resolving how IAP loss, TNFα signaling, and caspase activation shape tumor-cell death. This practical guide covers solvent handling, time-resolved assays, model selection, controls, and interpretation strategies for cancer research.

• Batimastat (BB-94): Transforming MMP Inhibition in Cancer an

  2026-08-07

  Batimastat (BB-94) empowers researchers to precisely dissect matrix metalloproteinase (MMP) function across cancer and neuromuscular synapse models, offering unmatched potency and workflow adaptability. This guide bridges breakthrough mechanistic insight from recent BDNF studies to actionable in vitro and in vivo protocols, troubleshooting, and translational opportunities.

• Bestatin Hydrochloride: Advanced Workflows for Angiogenesis

  2026-08-06

  Bestatin hydrochloride (Ubenimex) offers precise and reproducible inhibition of aminopeptidase N and B, empowering researchers to dissect angiogenesis, tumor invasion, and peptide signaling in both cancer and neuroscience models. This article provides actionable workflow enhancements, troubleshooting insights, and cross-domain applications, all grounded in robust experimental data and the pivotal findings of the reference study.

• Asymmetric Cu Single-Atom Nanozyme Modulates AMI Inflammatio

  2026-08-06

  This study introduces an asymmetrically coordinated copper single-atom nanozyme (Cu-BrN3/SAN@M) that demonstrates superior reactive oxygen species (ROS) scavenging and immune modulation in acute myocardial infarction (AMI) models. The findings point to the potential of rationally engineered nanozymes for targeted oxidative stress mitigation and improved post-infarction outcomes.

• JNK-IN-7: Selective JNK Inhibitor for Advanced Apoptosis Ass

  2026-08-05

  JNK-IN-7, a covalent JNK inhibitor, empowers researchers to precisely dissect MAPK signaling and apoptosis pathways in cell-based models. This article bridges innovative findings from infection biology with practical applications in kinase assay design, offering actionable protocols and troubleshooting tips for robust, reproducible results.

• High Viscosity Drives Chemoresistance via TRPV4-YAP-P-gp Pat

  2026-08-05

  This study reveals that high extracellular fluid viscosity in the tumor microenvironment directly promotes chemoresistance by upregulating P-glycoprotein (P-gp) through the TRPV4-YAP signaling axis. The findings highlight a mechanobiological mechanism for chemoresistance, suggesting that modulating tumor viscosity may enhance chemotherapeutic efficacy.

• Galectin-1 Impairs Autophagy and Drives Hepatic Steatosis vi

  2026-08-04

  This study uncovers galectin-1 as a direct suppressor of hepatic autophagy through its interaction with the scaffold protein FIP200, revealing a mechanistic link to the progression of non-alcoholic fatty liver disease (NAFLD). The findings introduce the Gal-1–FIP200 axis as a novel therapeutic target for metabolic liver disease and provide a framework for investigating autophagy dysregulation in metabolic disorder models.

• Redox-Responsive Peptide Coacervates Advance mRNA Delivery

  2026-08-04

  This study introduces HBpep-SS4, a single-component, redox-sensitive peptide coacervate for efficient mRNA encapsulation and glutathione-triggered cytosolic release. The approach achieves high gene editing efficiency and offers a biocompatible alternative to traditional lipid nanoparticles, with implications for safer, more controllable RNA delivery.

• Tomivosertib (SKU C8762): Reliable MNK1 Inhibition for Cell

  2026-08-03

  Tomivosertib (SKU C8762) is a highly selective MNK1/2 inhibitor that addresses core challenges in cell viability, proliferation, and cytotoxicity assays by providing reproducible, data-driven results. This article offers scenario-based guidance for optimizing experimental design, protocol execution, and product selection in biomedical research, with evidence-backed recommendations and direct links to validated protocols.

• Biomimetic Chromatography for Pulmonary Drug Permeability As

  2026-08-03

  This study directly compares immobilised artificial membrane liquid chromatography (IAM LC) and liposome electrokinetic capillary chromatography (LEKC) as models for predicting drug-membrane interactions relevant to pulmonary drug delivery. Core findings reveal that LEKC offers a more accurate simulation of lung permeability for ionisable drugs, while IAM LC provides broader applicability for compounds with diverse lipophilicity profiles.

• Epacadostat (INCB024360): Applied Workflows in Immuno-Oncolo

  2026-08-02

  Epacadostat (INCB024360) transforms immuno-oncology research by enabling precise modulation of IDO1-driven immune evasion. This guide bridges advanced metabolic immune assays with practical troubleshooting for robust preclinical insights.

• Annexin V-PE Apoptosis Detection Kit: Rapid Live-Cell Assays

  2026-08-01

  The Annexin V-PE Apoptosis Detection Kit empowers researchers with a streamlined, high-sensitivity workflow for quantifying early apoptosis in live cells—critical for immunology, drug screening, and cell death pathway studies. Its one-step, 10-minute protocol, leveraging phosphatidylserine binding protein technology, seamlessly integrates with both flow cytometry and fluorescence microscopy for robust, reproducible results.

• Müller Cell-Derived PEDF and Angiopoietin Signaling in Retin

  2026-07-31

  Recent research elucidates how Müller cell-derived pigment epithelium-derived factor (PEDF) is regulated by angiopoietin signaling to control retinal neuron survival. This mechanistic insight advances our understanding of neurovascular interactions relevant to ischemic and degenerative retinal diseases, highlighting actionable pathways for experimental neuroprotection.

• Batimastat (BB-94): MMP Inhibition in Synapse and Cancer Mod

  2026-07-31

  Batimastat (BB-94) unlocks precision control over extracellular matrix remodeling, empowering researchers to dissect MMP-dependent pathways in both tumor and neuromuscular synapse biology. This article details practical workflows, troubleshooting strategies, and the transformative insights enabled by BB-94, bridging cancer and neurodevelopmental research with rigor.

• 4-Hydroxytamoxifen: Technical Guidance for Lab Research Work

  2026-07-30

  4-Hydroxytamoxifen (SKU B6167) is a potent estrogen receptor modulator designed for DMSO-based protocols in breast and prostate cancer research, apoptosis assays, and cardiac myocyte studies. It should not be used in aqueous or ethanol-based workflows, and strict storage and handling are necessary to maintain reagent integrity.

16738 records 1/1116 page Next 12345 下5页 Last page